| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 4,645,283 | 4,656,302 | 4,743,048 | | Cost of Revenue | 2,787,854 | 2,815,959 | 2,851,616 | | | Gross Profit | 1,857,429 | 1,840,343 | 1,891,432 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,523,882 | 1,515,379 | 1,622,339 | | Non Recurring |
-
|
-
|
-
| | Others | 78,624 | 88,484 | 101,279 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 254,923 | 236,480 | 167,814 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65 | 5,236 | 3,257 | | Earnings Before Interest And Taxes | 254,988 | 241,716 | 171,071 | | Interest Expense | 5,282 | 2,513 | 581 | | Income Before Tax | 249,706 | 239,203 | 170,490 | | Income Tax Expense | 94,908 | 88,023 | 57,872 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 154,798 | 151,180 | 112,618 | | | Non-recurring Events | | Discontinued Operations | (3,251) | 7,281 | 11,427 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 151,547 | 158,461 | 124,045 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $151,547 | $158,461 | $124,045 |
|
1.07% Nasdaq 
Income Statement
